Phase I study of 5-azacytidine and oxaliplatin in patients with advanced cancers relapsed or refractory to platinum compounds

被引：0
|
作者：
Tsimberidou, Apostolia M. [1 ]
Culotta, Kirk [1 ]
Wistuba, Ignacio [1 ]
Fu, Siqing [1 ]
Naing, Aung [1 ]
Falchook, Gerald [1 ]
Piha-Paul, Sarina [1 ]
Zinner, Ralph [1 ]
Rodriguez-Canales, Jaime [1 ]
He, Guangan [1 ]
Siddik, Zahid H. [1 ]
Jelinek, Jaroslav [2 ]
Chung, Woonbok [2 ]
Ye, Yang [1 ]
Said, Rabih [3 ]
Hess, Kenneth [1 ]
Stewart, David J. [4 ]
Kurzrock, Razelle [5 ]
Issa, Jean-Pierre [2 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19122 USA
[3] UT Hlth Sci Ctr, Houston, TX USA
[4] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada
[5] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-CT201
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT201
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A Phase I/II Trial of 5-Azacytidine Prior to Gemtuzumab Ozogamicin (GO) for Patients with Relapsed Acute Myeloid Leukemia with Correlative Biomarker Studies.
    Ball, Edward D.
    Medeiros, Bruno C.
    Balaian, Larissa
    Roque, Tracy
    Corringham, Sue
    Rajwanshi, Richa
    Coutre, Steve
    Gotlib, Jason R.
    Bashey, Asad
    Messer, Karen
    BLOOD, 2009, 114 (22) : 809 - 809
  • [42] Update of a Phase I/II Trial of 5-Azacytidine Prior to Gemtuzumab Ozogamicin (GO) for Patients with Relapsed Acute Myeloid Leukemia with Correlative Biomarker Studies
    Ball, Edward D.
    Medeiros, Bruno C.
    Balaian, Larissa
    Roque, Tracy
    Corringham, Sue
    Rajwanshi, Richa
    Coutre, Steven
    Gotlib, Jason R.
    Bashey, Asad
    Messer, Karen
    BLOOD, 2010, 116 (21) : 1346 - 1346
  • [43] RESPONSE TO 5-AZACYTIDINE IN PATIENTS WITH REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA AND ASSOCIATION WITH CHROMOSOME FINDINGS
    LARSON, RA
    SWEET, DL
    GOLOMB, HM
    TESTA, JR
    ROWLEY, JD
    CLINICAL RESEARCH, 1981, 29 (04): : A762 - A762
  • [44] RESPONSE TO 5-AZACYTIDINE IN PATIENTS WITH REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA AND ASSOCIATION WITH CHROMOSOME FINDINGS
    LARSON, RA
    SWEET, DL
    GOLOMB, HM
    TESTA, JR
    ROWLEY, JD
    CANCER, 1982, 49 (11) : 2222 - 2225
  • [45] A phase 2 study of fluorouracil/leucovorin in combination with paclitaxel and oxaliplatin as a salvage treatment in patients with refractory or relapsed advanced gastric cancer
    Lin, Rongbo
    Fan, Nanfeng
    Wu, Guangfeng
    Chen, Ying
    Guo, Zengqing
    Wang, Xiaojie
    Jin, Feng
    Chen, Ling
    Liu, Jie
    JOURNAL OF CHEMOTHERAPY, 2015, 27 (01) : 52 - 56
  • [46] Trial in Progress: An Open-Label Phase II Study of Relatlimab with Nivolumab in Combination with 5-Azacytidine for the Treatment of Patients with Relapsed/Refractory and Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia (AARON)
    Buecklein, Veit L.
    Warm, Maximilian
    Spiekermann, Karsten
    Schmidt, Christian
    Unterhalt, Michael
    Daver, Naval
    Subklewe, Marion
    BLOOD, 2022, 140 : 3227 - 3228
  • [47] Phase I study of bexarotene and rosiglitazone in patients with refractory cancers
    Read, WL
    Govindan, R
    James, J
    Picus, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 232S - 232S
  • [48] A phase I study of bexarotene and rosiglitazone in patients with refractory cancers
    Read, William L.
    Baggstrom, Maria Q.
    Fracasso, Paula M.
    Govindan, Ramaswamy
    CHEMOTHERAPY, 2008, 54 (03) : 236 - 241
  • [49] Eribulin mesylate in patients with refractory cancers: a Phase I study
    Mukohara, Toru
    Nagai, Shunji
    Mukai, Hirofumi
    Namiki, Masayuki
    Minami, Hironobu
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (05) : 1926 - 1933
  • [50] Eribulin mesylate in patients with refractory cancers: a Phase I study
    Toru Mukohara
    Shunji Nagai
    Hirofumi Mukai
    Masayuki Namiki
    Hironobu Minami
    Investigational New Drugs, 2012, 30 : 1926 - 1933
12345